Grifols

Grifols Operating Cash Flow

The Operating Cash Flow of Grifols (GRF.MC) as of Nov 2, 2026 is 1.05 B EUR. In the previous year, Operating Cash Flow was 902.17 M EUR — a change of 16.05% (higher).

Operating Cash Flow

1.05 BEUR

YoY

16.05%

Last updated:

Operating Cash Flow of Grifols is 2025 1.05 B EUR. Operating Cash Flow of Grifols was 2024 902.17 M EUR. It decreases by 16.05% higher compared to the previous year.

The Grifols Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2018
737.43 M EUR
Jan 1, 2019
568.93 M EUR
Jan 1, 2020
1.11 B EUR
Jan 1, 2021
596.98 M EUR
Jan 1, 2022
-10.87 M EUR
Jan 1, 2023
208.28 M EUR
Jan 1, 2024
902.17 M EUR
Jan 1, 2025
1.05 B EUR
The Grifols Operating Cash Flow history
YEAROperating Cash FlowYoY
1.05 BEUR+16.05%
902.17 MEUR+333.15%
208.28 MEUR-2,016.66%
-10.87 MEUR-101.82%
596.98 MEUR-46.23%
1.11 BEUR+95.16%
568.93 MEUR-22.85%
737.43 MEUR-12.39%
841.75 MEUR+52.14%
553.28 MEUR-25.51%
742.78 MEUR-24.12%
978.93 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Grifols Stock analysis

What does Grifols do? Grifols SA is a globally operating company specialized in the manufacture and marketing of medical products and technologies. The company is headquartered in Barcelona, Spain and has been in existence for over 75 years. Grifols focuses on improving the quality of life through the production and marketing of blood products and services, diagnostics, and hospital pharmaceuticals. It has four main business areas: Bioscience, Hospital, Diagnostic, and Bio Supplies. Grifols emphasizes research and development to meet customer needs. It has introduced various products, including AlfaBIO, Vistogard, ID Core XT, NEO Blood Bank, and MIRASOL Pathogen Reduction Technology. Grifols is committed to innovation and quality, providing products and services that cater to a wide range of customers. Additionally, it is a significant employer in the biotechnology industry and contributes to economic development in different regions. Grifols is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Grifols stock

Operating Cash Flow of Grifols is 1.05 B EUR in 2025.

Operating Cash Flow of Grifols changed from 902.17 M EUR to 1.05 B EUR, representing a 16.05% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Grifols since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Grifols historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Grifols

All Key Metrics — Grifols